Your browser doesn't support javascript.
loading
The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
Ramchand, Sabashini K; Tsai, Joy N; Lee, Hang; Sassana-Khadka, Grace; Jordan, Mackenzie; Ryan, Savannah; Leder, Benjamin Z.
  • Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA. sramchand@mgh.harvard.edu.
  • Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Lee H; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
  • Sassana-Khadka G; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Jordan M; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Ryan S; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Leder BZ; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Osteoporos Int ; 35(2): 255-263, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37798320
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Conservadores de la Densidad Ósea Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Conservadores de la Densidad Ósea Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article